This supplement is based on the proceedings of a one-day round table meeting held at the National Heart and Lung Institute, London, in June 2007 to discuss findings of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. This international contemporary registry is looking at the association between multiple symptomatic locations of atherothrombosis (i.e. multi-vascular disease) and cardiovascular event rates, considering the characteristics and outcomes of stable patients in a community setting for whom one-year follow-up data were available. The registry is an ongoing study and the wide implications of this study for UK physicians across various different disciplines were discussed.
Optimising global risk reduction: insights from REACH
September 2007Br J Cardiol 2007;14(Suppl 3):S2-S16 Leave a commentClick any image to enlarge
Sponsorship Statement: This is a sponsored supplement to The British Journal of Cardiology. Details of sponsorship can be found by downloading the PDF.
Disclaimer: UK prescribing information current at the date of publication of this supplement can be found by downloading the PDF. Medinews Cardiology Limited advises healthcare professionals to consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews Cardiology Limited cannot accept responsibility for any errors in prescribing which may occur.
